Anaplastic Oligodendroglioma - 228 Studies Found
Terminated |
: Temozolomide and Ascorbic Acid in Treating Patients With Recurrent High-Grade Glioma :
: |
Completed |
: AZD8055 for Adults With Recurrent Gliomas :
|
Completed |
: BIBF 1120 for Recurrent High-Grade Gliomas :
: Drug: BIBF 1120 200 mg BID oral for 28 day cycle |
Terminated |
: (11C)dLop as a Marker of P-Glycoprotein Function in Patients With Gliomas :
|
Completed |
: A Randomized Phase II Trial of Vandetanib (ZD6474) in Combination With Carboplatin Versus Carboplatin Alone Followed by Vandetanib Alone in Adults With Recurrent High-Grade Gliomas :
|
Completed |
: Tandutinib Plus Bevacizumab to Treat Recurrent Brain Tumors :
: |
Completed |
: Imaging Study of the Distribution of IL13-PE38QQR Infused Before and After Surgery in Adult Patients With Recurrent Malignant Glioma :
|
Withdrawn |
: Photodynamic Therapy in the Treatment of Malignant Intracranial Tumors :
|
Completed |
: VEGF Trap in Treating Patients With Recurrent Malignant Gliomas That Did Not Respond to Temozolomide :
|
Completed |
: Sorafenib in Treating Patients With Recurrent or Progressive Malignant Glioma :
|